Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge
نویسندگان
چکیده
منابع مشابه
Pulmonary Arterial Hypertension: An Update
Introduction On first glance, a review of pulmonary arterial hypertension (PAH) in a journal that focuses on the health of the elderly may seem out of place. PAH is typically envisioned as a progressively disabling disease in young females. However, PAH is not a disease restricted to the young. Indeed, 20% of the patients followed in our pulmonary hypertension clinic are over the age of 65. Alt...
متن کاملAn Update on Pulmonary Arterial Hypertension.
Pulmonary arterial hypertension (PAH) is a progressive disease that ultimately leads to right heart failure and death. PAH is defined as a mean pulmonary arterial pressure ≥ 25 mm Hg with a pulmonary capillary wedge pressure ≤ 15 mm Hg at rest. The diagnosis of PAH is one of exclusion; diagnostics include an extensive history, serology, chest radiograph, pulmonary function tests, ventilation/pe...
متن کاملPulmonary arterial hypertension: an update
Pulmonary arterial hypertension (PAH), defined as group 1 of the World Heart Organisation (WHO) classification of pulmonary hypertension, is an uncommon disorder of the pulmonary vascular system. It is characterised by an increased pulmonary artery pressure, increased pulmonary vascular resistance and specific histological changes. It is a progressive disease finally resulting in right heart fa...
متن کاملPulmonary Arterial Hypertension in Systemic Sclerosis: Update on Current Treatment
PAH is defined as mean pulmonary pressure >25 mmHg at rest and >30 mmHg with exercise. The pathogenesis of PAH in systemic sclerosis involves endothelial cell injury. With endothelial cell dysfunction, there is reduced nitrous oxide and prostaglandin production, and increased endothelin-1 production. Vascular wall remodeling then follows with intimal and smooth muscle proliferation. Luminal nar...
متن کاملAnticoagulation increases survival in patients with idiopathic pulmonary arterial hypertension
A critical appraisal and clinical application of Olsson KM, Delcroix M, Ghofrani HA, et al. Anticoagulation and survival in pulmonary arterial hypertension: Results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation, 2014;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Heart and Lung Transplantation
سال: 2016
ISSN: 1053-2498
DOI: 10.1016/j.healun.2015.10.002